Review article · 2006 · Open access

Pharmacogenomics: Challenges and Opportunities

Dan M. Roden, Russ Biagio Altman, N L Benowitz, David Alastair Flockhart, Kathleen M. Giacomini, Julie A. Johnson, Ronald M. Krauss, Howard L. McLeod, Mark J. Ratain, Mary V. Relling, Huijun Z. Ring, Alan R. Shuldiner and 2 more

Annals of Internal Medicine, 145(10), 749–757 · Published 21 November 2006 · DOI 10.7326/0003-4819-145-10-200611210-00007

Open full textView at the publisherCite this paper

In brief

“Pharmacogenomics: Challenges and Opportunities” is a 2006 review article by Dan M. Roden and 13 co-authors, published in Annals of Internal Medicine. OpenAlex counts 323 citations as of 21 November 2026, which puts it in the top 3% of works published in 2006 by citations. It is open access: the full text is free to read at PubMed Central.

Citations
323
Most cited in
2025 (23)
Field-weighted impact
3.32
References
90
Authors
14

Abstract

The outcome of drug therapy is often unpredictable, ranging from beneficial effects to lack of efficacy to serious adverse effects. Variations in single genes are 1 well-recognized cause of such unpredictability, defining the field of pharmacogenetics (see Glossary). Such variations may involve genes controlling drug metabolism, drug transport, disease susceptibility, or drug targets. The sequencing of the human genome and the cataloguing of variants across human genomes are the enabling resources for the nascent field of pharmacogenomics (see Glossary), which tests the idea that genomic variability underlies variability in drug responses. However, there are many challenges that must be overcome to apply rapidly accumulating genomic information to understand variable drug responses, including defining candidate genes and pathways; relating disease genes to drug response genes; precisely defining drug response phenotypes; and addressing analytic, ethical, and technological issues involved in generation and management of large drug response data sets. Overcoming these challenges holds the promise of improving new drug development and ultimately individualizing the selection of appropriate drugs and dosages for individual patients.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., Ring, H. Z., Shuldiner, A. R., Weinshilboum, R. M., & Weiss, S. T. (2006). Pharmacogenomics: Challenges and Opportunities. Annals of Internal Medicine, 145(10), 749–757. https://doi.org/10.7326/0003-4819-145-10-200611210-00007

MLA 9

Roden, Dan M., et al. “Pharmacogenomics: Challenges and Opportunities.” Annals of Internal Medicine, vol. 145, no. 10, 2006, pp. 749–757. https://doi.org/10.7326/0003-4819-145-10-200611210-00007.

Chicago

Roden, Dan M., Russ Biagio Altman, N L Benowitz, David Alastair Flockhart, Kathleen M. Giacomini, Julie A. Johnson, Ronald M. Krauss, et al. 2006. “Pharmacogenomics: Challenges and Opportunities.” Annals of Internal Medicine 145 (10): 749–757. https://doi.org/10.7326/0003-4819-145-10-200611210-00007.

Harvard

Roden, D. M. et al. (2006) ‘Pharmacogenomics: Challenges and Opportunities’, Annals of Internal Medicine, 145(10), pp. 749–757. doi:10.7326/0003-4819-145-10-200611210-00007.

IEEE

D. M. Roden et al., “Pharmacogenomics: Challenges and Opportunities,” Annals of Internal Medicine, vol. 145, no. 10, pp. 749–757, 2006, doi: 10.7326/0003-4819-145-10-200611210-00007.

BibTeX

@article{roden2006pharmacogenomics,
  title     = {{Pharmacogenomics: Challenges and Opportunities}},
  author    = {Roden, Dan M. and Altman, Russ Biagio and Benowitz, N L and Flockhart, David Alastair and Giacomini, Kathleen M. and Johnson, Julie A. and Krauss, Ronald M. and McLeod, Howard L. and Ratain, Mark J. and Relling, Mary V. and Ring, Huijun Z. and Shuldiner, Alan R. and Weinshilboum, Richard M. and Weiss, Scott T.},
  journal   = {Annals of Internal Medicine},
  year      = {2006},
  volume    = {145},
  number    = {10},
  pages     = {749--757},
  doi       = {10.7326/0003-4819-145-10-200611210-00007},
  url       = {https://doi.org/10.7326/0003-4819-145-10-200611210-00007}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20171414
201844
20191010
202055
20211111
202288
20231111
20241313
20252323
20262020

Its field-weighted citation impact is 3.32: it has been cited 3.32 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacogenomics
  • pharmacogenetics
  • genetic variation
  • drug response variability
  • drug metabolism genes
  • drug transporters
  • therapeutic target
  • candidate genes

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., Ring, H. Z., Shuldiner, A. R., Weinshilboum, R. M., & Weiss, S. T. (2006). Pharmacogenomics: Challenges and Opportunities. Annals of Internal Medicine, 145(10), 749–757. https://doi.org/10.7326/0003-4819-145-10-200611210-00007

How many times has this paper been cited?

323 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Dan M. Roden, Russ Biagio Altman, N L Benowitz, David Alastair Flockhart, Kathleen M. Giacomini, Julie A. Johnson, Ronald M. Krauss, Howard L. McLeod, Mark J. Ratain, Mary V. Relling, Huijun Z. Ring, Alan R. Shuldiner and 2 more.

What is the DOI of this paper?

10.7326/0003-4819-145-10-200611210-00007, permanently at https://doi.org/10.7326/0003-4819-145-10-200611210-00007. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.